Single nucleotide polymorphisms (SNPs) in TMEM106B have since been identified as risk modifiers for a variety of neurodegenerative diseases including AD, hippocampal sclerosis (HS), and Parkinson’s Disease (PD) [18,24,29–32]. This evidence concerns the gene TMEM106B and Alzheimer disease.